Related references
Note: Only part of the references are listed.Utilization Trends and Volume-outcomes Relationship of Endoscopic Resection for Early Stage Esophageal Cancer
Nicole G. Jawitz et al.
ANNALS OF SURGERY (2023)
Cancer statistics, 2022
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
Pan-immune-inflammation value independently predicts disease recurrence in patients with Merkel cell carcinoma
T. Gambichler et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2022)
The preoperative pan-immune-inflammation value is a novel prognostic predictor for with stage I-III colorectal cancer patients undergoing surgery
Shun Sato et al.
SURGERY TODAY (2022)
Global challenges and policy solutions in breast cancer control
Dario Trapani et al.
CANCER TREATMENT REVIEWS (2022)
The Pan-Immune-Inflammation Value predicts the survival of patients with anaplastic lymphoma kinase-positive non-small cell lung cancer treated with first-line ALK inhibitor
Xinru Chen et al.
TRANSLATIONAL ONCOLOGY (2022)
The Systemic Immune-Inflammation Index is an Independent Predictor of Survival in Breast Cancer Patients
Mengliu Zhu et al.
CANCER MANAGEMENT AND RESEARCH (2022)
A New Prognostic Index in Young Breast Cancer Patients
Hacer Demir et al.
JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN (2022)
Usefulness of neutrophil-to-lymphocyte ratio (NLR) as a prognostic predictor after treatment of hepatocellular carcinoma
Mohamad Mouchli et al.
ANNALS OF HEPATOLOGY (2021)
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of outcomes in inflammatory breast cancer
Ouissam Al Jarroudi et al.
BIOMARKERS IN MEDICINE (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Breast cancer
Sibylle Loibl et al.
LANCET (2021)
The Pan-Immune-Inflammation-Value Predicts the Survival of Patients with Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Breast Cancer Treated with First-Line Taxane-Trastuzumab-Pertuzumab
Francesca Ligorio et al.
CANCERS (2021)
The Pan-Immune-Inflammation Value in microsatellite instability-high metastatic colorectal cancer patients treated with immune checkpoint inhibitors
Francesca Corti et al.
EUROPEAN JOURNAL OF CANCER (2021)
Low pan-immune-inflammation-value predicts better chemotherapy response and survival in breast cancer patients treated with neoadjuvant chemotherapy
Ahmet Bilgehan Sahin et al.
SCIENTIFIC REPORTS (2021)
Nomogram Based on Lactate Dehydrogenase-to- Albumin Ratio (LAR) and Platelet-to-Lymphocyte Ratio (PLR) for Predicting Survival in Nasopharyngeal Carcinoma
Ru-Rong Peng et al.
JOURNAL OF INFLAMMATION RESEARCH (2021)
Prediction of late recurrence in patients with breast cancer: elevated neutrophil to lymphocyte ratio (NLR) at 5 years after diagnosis and late recurrence
Gilseong Moon et al.
BREAST CANCER (2020)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Platelet/Lymphocyte Ratio Is Superior to Neutrophil/Lymphocyte Ratio as a Predictor of Chemotherapy Response and Disease-free Survival in Luminal B-like (HER2-) Breast Cancer
Yuanping Hu et al.
CLINICAL BREAST CANCER (2020)
Dynamic Neutrophil-to-Lymphocyte Ratio: A Novel Prognosis Measure for Triple-Negative Breast Cancer
Dan Moldoveanu et al.
ANNALS OF SURGICAL ONCOLOGY (2020)
The Pan-Immune-Inflammation Value is a new prognostic biomarker in metastatic colorectal cancer: results from a pooled-analysis of the Valentino and TRIBE first-line trials
Giovanni Fuca et al.
BRITISH JOURNAL OF CANCER (2020)
High Systemic Immune-Inflammation Index Predicts Poor Survival in Patients with Human Epidermal Growth Factor Receptor-2 Positive Breast Cancer Receiving Adjuvant Trastuzumab
Li Jiang et al.
CANCER MANAGEMENT AND RESEARCH (2020)
Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide in Elderly Patients With Valvular Heart Disease
Bin Zhang et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Prognostic Value of Preoperative Systemic Immune-Inflammation Index in Breast Cancer: A Propensity Score-Matching Study
Xin Hua et al.
FRONTIERS IN ONCOLOGY (2020)
Prognostic value of the systemic immune-inflammation index in patients with breast cancer: a meta-analysis
Yantao Zhang et al.
CANCER CELL INTERNATIONAL (2020)
Metabolic dysfunction and early-onset colorectal cancer - how macrophages build the bridge
Katharina M. Scheurlen et al.
CANCER MEDICINE (2020)
Neutrophil to lymphocyte ratio and cancer prognosis: an umbrella review of systematic reviews and meta-analyses of observational studies
Meghan A. Cupp et al.
BMC MEDICINE (2020)
Systemic Immune-Inflammation Index Is Superior to Neutrophil to Lymphocyte Ratio in Prognostic Assessment of Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy
Cong Jiang et al.
BIOMED RESEARCH INTERNATIONAL (2020)
Immune Escape Mechanisms in Non Small Cell Lung Cancer
Andrea Anichini et al.
CANCERS (2020)
Combination of peripheral neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients
Vincenzo Graziano et al.
BREAST (2019)
The assessment of 8th edition AJCC prognostic staging system and a simplified staging system for breast cancer: The analytic results from the SEER database
Jingting Zhang et al.
BREAST JOURNAL (2019)
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
Florian R. Greten et al.
IMMUNITY (2019)
Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio for breast cancer patients: An updated meta-analysis of 17079 individuals
Wanying Guo et al.
CANCER MEDICINE (2019)
Analysis of Hematological Traits in Polled Yak by Genome-Wide Association Studies Using Individual SNPs and Haplotypes
Xiaoming Ma et al.
GENES (2019)
Effect of Anesthetic Technique on the Occurrence of Acute Kidney Injury after Total Knee Arthroplasty
Ha-Jung Kim et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update
Antonio C. Wolff et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Prognostic value of systemic inflammatory markers and development of a nomogram in breast cancer
Uiju Cho et al.
PLOS ONE (2018)
TNFα-activated mesenchymal stromal cells promote breast cancer metastasis by recruiting CXCR2+ neutrophils
P. F. Yu et al.
ONCOGENE (2017)
Risk Factors and Preventions of Breast Cancer
Yi-Sheng Sun et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2017)
Platelets reduce anoikis and promote metastasis by activating YAP1 signaling
Monika Haemmerle et al.
NATURE COMMUNICATIONS (2017)
Comparison of the prognostic values of preoperative inflammation-based parameters in patients with breast cancer
Hideya Takeuchi et al.
PLOS ONE (2017)
Breast Cancer: Multiple Subtypes within a Tumor?
Syn Kok Yeo et al.
TRENDS IN CANCER (2017)
Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis
Josee-Lyne Ethier et al.
BREAST CANCER RESEARCH (2017)
Tumor-Associated Neutrophils Recruit Macrophages and T-Regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib
Shao-Lai Zhou et al.
GASTROENTEROLOGY (2016)
Usefulness of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in hormone-receptor-negative breast cancer
Chao Liu et al.
ONCOTARGETS AND THERAPY (2016)
The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients
S. Krenn-Pilko et al.
BRITISH JOURNAL OF CANCER (2014)
Systemic Immune-Inflammation Index Predicts Prognosis of Patients after Curative Resection for Hepatocellular Carcinoma
Bo Hu et al.
CLINICAL CANCER RESEARCH (2014)
STAT3 and sphingosine-1-phosphate in inflammation-associated colorectal cancer
Andrew V. Nguyen et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Chronic Inflammation and Cytokines in the Tumor Microenvironment
Glauben Landskron et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2014)
Validation of the prognostic relevance of plasma C-reactive protein levels in soft-tissue sarcoma patients
J. Szkandera et al.
BRITISH JOURNAL OF CANCER (2013)
Molecular Pathways: The Complex Roles of Inflammation Pathways in the Development and Treatment of Liver Cancer
Kostas Nikolaou et al.
CLINICAL CANCER RESEARCH (2013)
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
Antonio C. Wolff et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Tumor-Associated Neutrophils: New Targets for Cancer Therapy
Alyssa D. Gregory et al.
CANCER RESEARCH (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Immunity, Inflammation, and Cancer
Sergei I. Grivennikov et al.
CELL (2010)
The three Es of cancer immunoediting
GP Dunn et al.
ANNUAL REVIEW OF IMMUNOLOGY (2004)
Share Paper
